Friday – April 13, 2018

09.00 – 09.10       WELCOME REMARKS  
Francesco Bandello                         

RETINAL VASCULAR DISEASES 1

Chairpersons: Teresio Avitabile, Leonardo Mastropasqua, Ugo Menchini

09:10 – 09:20       OCT ANGIOGRAPHY IN OPTIC NERVE DISEASE
Piero Barboni 

09:20 – 09:30       TBD
Jose Pulido

09.30 – 09.40       DRIL AND RETINAL FUNCTION IN DIABETIC MACULAR EDEMA
Usha Chakravarthy

09.40 – 09.50       MICROVASCULAR CHANGES IN DIABETIC RETINOPATHY EVALUATED WITH OCTA OVER TIME
Maria Cristina Parravano 

09.50 – 10.00       QUANTITATIVE TRACKING OF LIPID EXUDATION IN DIABETIC MACULAR EDEMA
SriniVas Sadda

10.00 – 10.10       MULTIMODAL IMAGING OF DIABETIC RETINOPATHY
José Cunha-Vaz

10.10 – 10.20       DO ANTI VEFG INJECTIONS IN DIABETIC RETINOPATHY RESULT IN RETINAL REPERFUSION ON WIDE FIELD OCTA?
Alain Gaudric                                       

10.20 – 10.30       BIOMARKERS FOR THE TREATMENT OF DME
Anat Loewenstein

10.30 – 10.40       OCTA AND ELECTROPHYSIOLOGIC INSIGHTS IN EARLY DIABETES
Edoardo Midena

10.40 -10.50        ANTI-VEGF AND NON PERFUSION
Sobha Sivaprasad

10.50 – 11.00       DISCUSSION

11.00 – 11.30       COFFEE BREAK                                                                                                                    

AMD 1

Chairpersons: Francesco Bandello, Rosario Brancato, Giuseppe Guarnaccia

11.30 – 11.40      OCTA OF TYPE 3 NV: LINKING THE DEEP CAPILLARY PLEXUS AND THE CHOROID
David Sarraf

11.40 – 11.50       CHANGES IN MACULAR CHORIOCAPILLARIS PERFUSION ASSOCIATED WITH AGING AND AMD USING SWEPT SOURCE OCT ANGIOGRAPHY
Philip J. Rosenfeld

11.50 – 12.00       UNDERSTANDING ANEURYSMAL TYPE 1 NEOVASCULARIZATION, AKA POLYPOIDAL CHOROIDAL VASCULOPATHY
K. Bailey Freund

12.00 – 12.10       SENSITIVITY AND SPECIFICITY OF OCTA IN THE DETECTION OF NEOVASCULAR AMD
Usha Chakravarthy

12.10 – 12.20       DRUSENOID DETACHMENT OF THE RPE : LIFE CYCLE
Lawrence A. Yannuzzi                          

12.20 – 12.30       3-YEAR FOLLOW-UP OF CNV BY OCTA
Bruno Lumbroso

12.30 – 12.40       HAWK & HARRIER: 48–WEEK RESULTS OF TWO MULTI-CENTERED, RANDOMIZED, DOUBLE-MASKED TRIALS OF BROLUCIZUMAB VERSUS AFLIBERCEPT FOR NEOVASCULAR AMD
Francesco Bandello   

12.40 – 12.50       SIMULATING “SWITCHING” OF ANTIVEGF AGENTS IN HARBOR AMD PATIENTS
Marco A. Zarbin

12.50 – 13.00       DISCUSSION

13.00 – 14.30      LUNCH BREAK
                                 VISIT THE EXHIBITION
                                 ACTIVITIES IN THE OCT LOUNGE ROOMS **
                                 (SESSIONE NON ACCREDITATA ECM)

CASE STUDIES

14.30 –  14.40      BILATERAL PALE OPTIC NERVES WITH A PERIVASCULAR SHEATHING IN THE POSTERIOR POLE
Chiara Maria Eandi

14.40 – 14.50       VITRITIS: TOWARD THE UNKNOWN OR TOWARD THE IDIOPATHIC?
Lorenzo Iuliano

14.50 – 15.00       PROLIFERATIVE DIABETIC RETINOPATHY AND MACULAR EDEMA
Massimo Nicolò

15.00 – 15.10       MYSTERY CASE
Francesco Viola

15.10 – 15.20       AN UNUSUAL CENTRAL SEROUS CHORIORETINOPATHY
Stela Vujosevic

15.20 – 15.30       MYSTERY CASE
Vittorio Capuano

15.30 – 15.40       MYSTERY CASE
K. Bailey Freund

15.40 – 15.50       MYSTERY CASE
Philip J. Rosenfeld

15.50 – 16.00       MYSTERY CASE
SriniVas R. Sadda

16.00 – 16.10       MYSTERY CASE
Lawrence A. Yannuzzi

16.10 – 16.20       MYSTERY CASE
Usha Chakravarthy

16.20 – 16.30       MYSTERY CASE
Anat Loewenstein

16.30 – 16.40       MYSTERY CASE
David Sarraf

16.40 – 16.50       MYSTERY CASE
Emmet Cunninghamm

16.50 – 17.00       MYSTERY CASE
Jose Pulido

17.00 – 18.00       PANEL DISCUSSION ON THE TOPICS ABOVE MENTIONED
Usha Chakravarthy, José Cunha-Vaz, Emmet Cunninghamm, K. Bailey Freund, Anat Loewenstein, Jose Pulido, Philip J. Rosenfeld, SriniVas R. Sadda, David Sarraf, Sobha Sivaprasad, Lawrence A. Yannuzzi, Marco A. Zarbin